Related Experiment Video
Updated: Feb 6, 2026
13:32
High Content Screening in Neurodegenerative Diseases
Published on: January 6, 2012
18.1K
APP-C31 pathology as a target in neurodegenerative diseases
King Chi Yip1, Woon Fei Ho2, Yang Liu3
1Department of Biomedical Science, College of Biomedicine, City University of Hong Kong, Kowloon, 999077, Hong Kong, China.
Journal of Biomedical Science
|February 4, 2026
Summary
Amyloid precursor protein C31 (APP-C31) is a key mediator in neurodegeneration, acting as a central executioner that bridges stress triggers to neuronal loss. Understanding APP-C31
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Neurodegenerative diseases involve progressive neuronal loss, impacting millions globally.
- Amyloid precursor protein (APP) and its cleavage products, like APP-C31, are implicated in neurodegeneration.
- Current research focuses on understanding neurodegenerative mechanisms and developing therapeutic strategies.
Purpose of the Study:
- To comprehensively review the structure, neurotoxicity, and regulatory mechanisms of APP-C31.
- To explore the clinical relevance of APP-C31 in neurodegenerative diseases.
- To evaluate the therapeutic potential of APP-C31 as a drug target.
Main Methods:
- Literature review of existing research on APP-C31.
- Analysis of studies on APP-C31 structure and function.
- Synthesis of data regarding APP-C31's role in disease pathology.
Main Results:
- APP-C31 exhibits significant neurotoxicity.
- APP-C31 is regulated through complex cellular mechanisms.
- APP-C31 is linked to the pathogenesis of various neurodegenerative conditions.
Conclusions:
- APP-C31 is hypothesized to be a critical "central executioner" in neurodegeneration.
- APP-C31 acts as a signaling hub, driving multiple pathogenic pathways.
- Targeting APP-C31 offers potential therapeutic strategies for neurodegenerative diseases.
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
1.1K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
01:25Immunodeficiency Diseases
2.4K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
2.4K
02:57Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
01:24Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
01:22Alzheimer's Disease: Treatment
959
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
959
01:26Principles of Disease Surveillance
554
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
554